Zowin
- Company typePrivate
- Founded2015
- HeadquartersSeoul, South Korea
- Headcount—
- GTM typeB2B and B2C
- OfferingServices
Zowin firmographics
Firmographics- Name
- Zowin
- Legal name
- (주)조윈|JOWIN Healthcare Platform
- Website
- https://jowin.info
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Ownership category
- akta.pro rank
Zowin industry classification
Industry- Product category
- Preventive Healthcare Services
- NAICS
- Home Health Care Services (62161), Food (Health) Supplement Retailers (456191)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Services-Health Services (8000)
- akta.pro primary industry
- Virtual Preventive Care & Wellness Coaching (incl. lifestyle medicine) (HLALADAK)
- akta.pro secondary industries
- Chronic Disease Remote Monitoring (COPD/CHF/HTN, Weight & Symptom Tracking) (HLAHACAI), Specialty Condition Supplements (Sleep, Stress, Heart, Joint, Gut, Immunity) (CRADAGAE), Chronic Condition Lifestyle Coaching (Non-Clinical) (HSADAGAH)
Keywords
Where Zowin is headquartered
LocationHeadquarters
- HQ city
- Seoul
- HQ country
- South Korea
- HQ region
- Asia
Offices1 record
Markets served
Zowin business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain, Infrastructure
Revenue model
- Health Subscription Products: Regular subscription model for preventive nutritional supplements, health devices, and functional health products. Customers subscribe monthly to nutritional supplements and health devices, generating recurring revenue. The subscription automatically links to insurance coverage.
- MIT Therapy Products & Services: Revenue from proprietary Micacine (운비제) mineral-based therapeutic products and DR. K-CURE high-frequency hyperthermia devices. Products include both professional institutional models and personal home care models with home rental options.
- Health-Insu License Fees: Licensing revenue from the Health-Insu certification system. Partner companies selling verified health products through the Health-Insu platform pay licensing fees. Companies can apply for Health-Insu license through the official application process.
- Insurance Partnership Revenue: Revenue from partnerships with insurance companies including Hyundai Marine & Fire Insurance (현대해상) and 5 other domestic and overseas insurers for co-development of Health-Insu linked insurance products.
- Partnered Health Product Sales: Revenue from sales of certified partner products including Dr's PGA Immunity Up, Jinsenginsoo (진생인수), and Exoden through the Health-Insu platform.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Multi-year contract | MIT Therapy Social Contribution Program for cancer patients - subsidized rate |
| Subscription | Monthly | Health-Insu Subscription with automatic insurance linkage |
| Subscription | Monthly | DR. K-CURE Home Care Model - home rental program |
Go-to-market motion2 records
Distribution channels5 records
Marketing channels7 records
Zowin product offering
Product offeringCore offering
JOWIN operates an integrated preventive healthcare platform that combines certified nutritional supplements, hyperthermia medical devices, digital health applications, and insurance-linked subscription services under the Health-Insu (헬스인슈) brand. Its therapeutic business is anchored by the MIT Therapy program, which pairs the proprietary Micacine (운비제) mineral-based supplement with the DR. K-CURE 43°C high-frequency hyperthermia device for cancer and chronic disease care. The platform is sold both to individual consumers via monthly subscriptions and to partner companies, hospitals, and insurers via licensing and distribution agreements.
Product overview
JOWIN operates as an integrated healthcare ecosystem spanning prevention through treatment and recovery, built around three core business areas: Health-Insu™ platform (preventive nutrition subscription with insurance integration), MIT Therapy (cancer and chronic disease care combining Micacine mineral therapeutics and DR. K-CURE hyperthermia), and Lifetime Healthcare Solutions (data-driven anti-aging and precision medicine). The Health-Insu™ platform serves as the core subscription model, connecting preventive nutritional supplements and health devices with insurance protection, verified through insurance loss ratio data and hospital clinical screening data. MIT Therapy integrates proprietary products (Micacine/Unbije, DR. K-CURE) with cancer management programs. The ecosystem extends through HI-Clinic hospital partnership networks, partnered Health-Insu certified products (Dr's PGA Immunity Up, Jinsenginsoo, Exoden), and social contribution initiatives including KQ-ART healing art and MIT Therapy donation programs. The company also offers Cancerport, a psychological counseling app for cancer patients.
Differentiator
Problem solved
Functional benefit
Brands
- Health-Insu™: 보험 연계형 건강관리 플랫폼 - 예방 영양제, 정기검진, 맞춤형 보험보장이 결합된 통합 헬스케어 서비스
- MIT Therapy™
- 운비제(Micacine)
- DR. K-CURE
- 캔서포트(CancerPort)
- KQ-ART
Products and services
- Health-Insu (헬스인슈) Integrated Care Platform Subscription-based integrated preventive care platform that links certified nutritional supplements, home health devices, clinical screening, and insurance coverage into a single member offering for South Korean consumers.
- Micacine (운비제) Proprietary mineral-based nutritional therapeutic, formulated from the company's controlled sericite supply, used to support immune function and as the supplement component of the MIT Therapy cancer and chronic-disease protocol.
- DR. K-CURE High-Frequency Hyperthermia System 43°C high-frequency hyperthermia medical device used in MIT Therapy for cancer and chronic-disease care, deployed in the HI-Clinic hospital network and through international hospital partners.
- MIT Therapy Program Integrated adjuvant cancer and chronic-disease care program that combines the Micacine mineral supplement with the DR. K-CURE 43°C high-frequency hyperthermia device, offered to individual patients and through clinical partners.
- Cancerport Psychological Counseling Application Mobile/web application delivering psychological counseling and emotional support services for cancer patients and their families, integrated with JOWIN's broader MIT Therapy care offering.
- Cansalgi (캔살기) Personal Hyperthermia Device Personal-use hyperthermia device introduced for home rental by cancer and chronic-disease patients as a consumer/home counterpart to the clinical DR. K-CURE system.
- Lifetime Healthcare Solution Genomic and preventive-health testing program that maps individual disease risk profiles (including cancer, dementia, and other conditions) and feeds personalized supplement and lifestyle recommendations through the Health-Insu platform.
Quantifiable outcome
- NK and T-cell activation-based immune enhancement clinically demonstrated at 52.3% immune activation rate
- +2 more outcomes
Companies that use Zowin
Customer profileNamed customers3 records
Segments5 records
Ideal customer profiles4 records
Zowin technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability5 records
Feature7 records
Zowin partnerships and signals
Strategic signalPartnerships
16 partnerships are on record, tiered core, minor and flagship.
- Buk Seoul Geriatric Hospital (북서울요양병원)coreClinical observation partnership for treating terminal and advanced cancer patients. Agreement for MITT Cancer Solution observation clinical trial signed June 2025 with Buk Seoul Geriatric Hospital.
- Gogorealbox (고고리얼박스)minorJoint operation of a cancer patient referral product shopping platform. Gogorealbox partnered with JOWIN to jointly operate a shopping platform recommending products for cancer patients.
- Sanggye Gangwon Medical Institution - 상경원인터메드요양병원coreObservation clinical partnership for terminal stage 4 cancer patients. SKJ Sanggye-intermediate and JOWIN collaborated on ORT Therapy observation clinical trial for cancer patients. Announced December 2024.
- IMPRIMED (임프리메드)coreJoint research and development partnership for AI precision medical-based optimal anticancer adjuvant development. Combines JOWIN's cancer care expertise with IMPRIMED's AI precision medicine technology.
- MindCafe (마인드카페)corePartnership for developing cancer patient counseling service platform. Aimed at creating a mental health support platform for cancer patients, combining MindCafe's counseling expertise with JOWIN's cancer care ecosystem.
- Hi-Zen Care (하이젠케어)flagshipHi-Zen Care serves as the master distribution partner for the entire Health-Insu platform, managing overall product circulation and partner relationship management. Website: hijowin.co.kr.
- Ham Partners Group (함파트너스그룹)coreAdvertising and marketing partnership for brand and campaign planning and integrated promotional operations. Manages brand campaigns and promotional activities for the Health-Insu ecosystem.
- Moalifeplus (모아라이프플러스)coreHealth product supply partner providing preventive nutritional supplements and Health-Insu products. Also serves as distribution channel for partnered products including Dr's PGA Immunity Up.
- Koryuwon (고려원)coreHealth product supply partner specializing in Korean traditional herbal formulations. Provider of Jinsenginsoo (진생인수) product with proprietary MSM and Korean ginseng saponin (ginsenoside) complex formula.
- Lifeonbio (라이프온)coreHealth product supply partner contributing to the Health-Insu product portfolio and preventive nutritional supplement ecosystem.
- Mediage (메디에이지)coreHealth data partnership for bio data-based health indicator analysis and clinical collaboration. Provides health data analytics capabilities for the Health-Insu data verification system.
- Hyundai Marine & Fire Insurance (현대해상) and 5 additional insurance companiesflagshipInsurance partnership for co-development of Health-Insu linked insurance products. Insurance companies provide loss ratio data for product efficacy verification and receive access to Health-Insu subscription model for risk management. Partnership with Hyundai Marine & Fire Insurance (hi.co.kr) plus 5 additional domestic and overseas insurers.
- ATAKA Co. LTDminorAnticancer product licensing agreement with Japanese company ATAKA Co. LTD. Involves licensing of JOWIN's anticancer product technology or formulations.
- Wellness Medi (Philippines)coreExclusive global distribution partnership for the Philippine market. Brings JOWIN's Health-Insu ecosystem and products to Southeast Asian markets through exclusive licensing arrangement.
- HL GROUP (Bangladesh)minorPartnership with Bangladesh-based HL GROUP for global market entry. Represents JOWIN's expansion into South Asian markets through local partner representation.
- Noble HospitalsminorCooperation agreement with Noble Hospitals for medical collaboration. Part of the HI-Clinic network expansion and international hospital partnership strategy.
Scale indicators7 records
Recent moves6 records
Expansion highlights5 records
Zowin competitors and assessment
Company assessmentEmerging players
- Oscar Health: US health insurer building a tech-led platform that integrates insurance with care navigation and preventive health data. Closest comparable to JOWIN's insurance-embedded preventive healthcare concept, though operating in a different regulatory and reimbursement environment.
- Ritual: US subscription-based supplements company with traceable, clinically validated ingredients. Comparable to JOWIN's data-verified nutrition subscription model and target segment of health-conscious preventive care consumers.
- Bukwang Pharmaceutical: Korean pharmaceutical company with prescription drugs, OTC products, and consumer health supplements including CNS and metabolic therapy areas. Comparable to JOWIN in the Korean health functional food and integrative care space.
Broad incumbents
- Celltrion: Major Korean biopharmaceutical company with biosimilars, biologics, and growing consumer health portfolio. A broad incumbent in the Korean healthcare market and a potential partner/acquirer for JOWIN's oncology and supplement businesses.
- Genexine: Korean clinical-stage biotech developing immunotherapies and DNA vaccines, including oncology candidates. Comparable to JOWIN's cancer immunotherapy positioning and Korean biotech R&D pipeline.
- Kwang Dong Pharmaceutical: Korean pharmaceutical and health functional food manufacturer with broad consumer health and OTC presence. Comparable to JOWIN's supplement and functional health products distributed via pharmacy and consumer channels in Korea.
- Hims & Hers Health: US direct-to-consumer telehealth and wellness subscription platform combining personalized supplements, prescription products, and health services. Comparable to JOWIN's subscription-based Health-Insu D2C model for preventive health and nutrition.
Direct peers
- Pyrexar Medical: US-based manufacturer of hyperthermia/cancer treatment devices using radiofrequency and microwave technology to heat deep tissue. Directly comparable to JOWIN's DR. K-CURE high-frequency hyperthermia system targeting the same oncology adjunctive therapy use case.
- Yuyu Pharma: Korean pharmaceutical company with consumer health supplements, OTC products, and medical device portfolio. Most direct Korean peer in the supplement/functional health product distribution and hospital channel business.
- Oncotherm: German-Hungarian developer of capacitive hyperthermia devices (EHY-2000, EHY-2030) for cancer treatment. Most direct global competitor to JOWIN's DR. K-CURE in the localized deep-tissue hyperthermia category.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights6 records
Customer concentration
Zowin social profiles
Digital presenceZowin compliance and trust
Trust signalCompliance1 record
Zowin financial estimates
Financial estimateRevenue estimate
Valuation estimate
Zowin leadership team
Management profileNumber of profiles
Zowin funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Zowin M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Zowin
What does Zowin do?
JOWIN operates an integrated preventive healthcare platform that combines certified nutritional supplements, hyperthermia medical devices, digital health applications, and insurance-linked subscription services under the Health-Insu (헬스인슈) brand. Its therapeutic business is anchored by the MIT Therapy program, which pairs the proprietary Micacine (운비제) mineral-based supplement with the DR. K-CURE 43°C high-frequency hyperthermia device for cancer and chronic disease care. The platform is sold both to individual consumers via monthly subscriptions and to partner companies, hospitals, and insurers via licensing and distribution agreements.
Is Zowin a public or private company?
Zowin is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Zowin founded?
Zowin was founded in 2015.
Where is Zowin based?
Zowin is headquartered in Seoul, South Korea, in the Asia region.
How does Zowin make money?
Five revenue lines are on record. Health Subscription Products are the primary driver. The others are MIT Therapy Products & Services, health-Insu License Fees, insurance Partnership Revenue and partnered Health Product Sales.
Who are Zowin's main competitors?
Emerging players on record are Oscar Health, Ritual and Bukwang Pharmaceutical. Broad incumbents are Celltrion, Genexine, Kwang Dong Pharmaceutical and Hims & Hers Health. Direct peers are Pyrexar Medical, Yuyu Pharma and Oncotherm.
Does Zowin have an API?
No public API is recorded for Zowin.
What industry is Zowin in?
Zowin's product category is Preventive Healthcare Services. Its primary akta.pro industry code is HLALADAK, Virtual Preventive Care & Wellness Coaching (incl. lifestyle medicine), with a secondary code of HLAHACAI, Chronic Disease Remote Monitoring (COPD/CHF/HTN, Weight & Symptom Tracking). Its NAICS code is 62161 and its SIC code is 3845.